Genetic variant
rs16969968 a variant in the CHRNA5 gene
rs16969968 is a single-letter difference in the CHRNA5 gene, on chromosome 15. ClinVar, the public archive of variant interpretations, lists it as drug response: linked to how the body handles certain medicines. It has been reported in connection with Lung cancer susceptibility 2 and Smoking as a quantitative trait locus 3, among others. Carrying it does not, on its own, mean you have or will develop any condition.
What is this?
Your DNA is a long sequence of four letters. At a few million positions, people commonly differ by a single letter; each of those positions is called a SNP (“snip”), and rs16969968 is the catalogue number of one of them, in the CHRNA5 gene. Which letters you carry there — one copy from each parent — is your genotype.
CHRNA5 (cholinergic receptor nicotinic alpha 5 subunit): The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010]
Gene description from NCBI Gene
Associated with smoking phenotype (p=0.007) based on association study of 2,000 individuals, and fu...
From SNPedia
Why might it matter?
ClinVar records this variant as drug response, meaning linked to how the body handles certain medicines. A classification describes the variant, not you: what it means for one person depends on their genotype, their family history and often on other genes and circumstances.
Conditions it has been reported with
- Lung cancer susceptibility 2
- Smoking as a quantitative trait locus 3
- nicotine response - Toxicity
- Susceptibility to severe coronavirus disease (COVID-19) due to high levels of fibrinogen and C-reactive protein
Listed in ClinVar submissions for this variant. Being listed is a report of an association, not a statement that the variant causes the condition in any given person.
Do I have this variant?
If you have taken a consumer DNA test (23andMe, AncestryDNA and similar), you can download its raw data file and check. Create a free account, upload the file, and this page will show the letters you carry at rs16969968, if your test read this position.
Connect this with your blood results
A gene is a fixed instruction; a blood test shows what your body is doing now. CheckMyBloods reads the two side by side, so a variant can be set against the markers it could plausibly affect.
Blood markers do not diagnose a genetic condition, and a variant does not explain a blood result on its own. Together, with symptoms and family history, they give a clinician context.
What should I do next?
- Find out whether you carry it. Reading about a variant says nothing about you until you know your genotype.
- Put it in context. Add your blood results, so the variant can be read against what your body is doing.
- Ask questions. Dr. Hemsworth, our AI assistant, can explain this variant and your results in plain English.
- Take anything that worries you to a professional. A GP or genetic counsellor can order a confirmatory test and interpret it with your history.
This page is general information drawn from public research databases. It cannot diagnose anything, and it is not a substitute for advice from a doctor or genetic counsellor who knows your history.
Technical details
- dbSNP ID
- rs16969968
- Gene
- CHRNA5
- Position (GRCh38)
- chr15:78590582
- Variant type
- snv
- Consequence
- missense variant
- ClinVar classification
- drug response
Genome-wide association studies (15)
| Trait | Risk allele | OR / beta | P-value | Study |
|---|---|---|---|---|
| Smoking behaviour (cigarettes smoked per day) | A | β 0.096 | 3E-139 | PubMed |
| Lung cancer | A | OR 0.22 | 2E-54 | PubMed |
| Fagerstrӧm test for nicotine dependence | G | OR 0.23 | 4E-28 | PubMed |
| Chronic obstructive pulmonary disease | A | OR 1.11 | 5E-25 | PubMed |
| Small cell lung carcinoma | — | OR 0.26 | 1E-23 | PubMed |
| Time to smoke first cigarette in the morning | G | β 0.07 | 1E-17 | PubMed |
| Post bronchodilator FEV1/FVC ratio | A | β 0.017 | 1E-15 | PubMed |
| Post bronchodilator FEV1 | A | β 0.078 | 6E-15 | PubMed |
| Cryptic phenotype that captures alpha-1-antitrypsin deficiency severity | A | β 0.006 | 3E-12 | PubMed |
| Pre bronchodilator FEV1/FVC ratio | — | β 0.017 | 2E-10 | PubMed |
| Chronic airway obstruction (time to event) x smoking status interaction | — | — | 8E-10 | PubMed |
| Pre bronchodilator FEV1 | — | β 0.08 | 2E-9 | PubMed |
| Chronic airway obstruction (time to event) x smoking status interaction | — | — | 6E-9 | PubMed |
| ICD10 Z72.0: Tobacco use | — | — | 2E-7 | PubMed |
| Post bronchodilator FEV1/FVC ratio in COPD | A | β 0.012 | 4E-7 | PubMed |
ClinVar submissions (7)
How common the less frequent letter is
- gnomAD ALL
- 30.8%
- 1kG AFR
- 2.3%
- 1kG ALL
- 15%
- 1kG AMR
- 20.9%
- 1kG EAS
- 97.3%
- 1kG EUR
- 63.4%
- 1kG SAS
- 18.2%
Sources
- dbSNP: rs16969968 — the reference record
- ClinVar — clinical interpretations submitted by laboratories
- SNPedia — community-written summaries
- NCBI Gene: CHRNA5
- Ensembl: CHRNA5
- GWAS Catalog — association studies